Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE)
Authors:
Open Access
- 18 May 2022
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 45 (8) , 1074-1089
Abstract
Background: To analyze long-term oncological outcomes of open and percutaneous thermal ablation in the treatment of patients with colorectal liver metastases (CRLM). Methods: This assessment from a prospective, longitudinal tumor registry included 329 patients who underwent 541 procedures for 1350 CRLM from January 2010 to February 2021. Three cohorts were formed: 2010–2013 (129 procedures [53 percutaneous]), 2014–2017 (206 procedures [121 percutaneous]) and 2018–2021 (206 procedures [135 percutaneous]). Local tumor progression-free survival (LTPFS) and overall survival (OS) data were estimated using the Kaplan–Meier method. Potential confounding factors were analyzed with uni- and multivariable Cox regression analyses. Results: LTPFS improved significantly over time for percutaneous ablations (2-year LTPFS 37.7% vs. 69.0% vs. 86.3%, respectively, P < .0001), while LTPFS for open ablations remained reasonably stable (2-year LTPFS 87.1% [2010–2013], vs. 92.7% [2014–2017] vs. 90.2% [2018–2021], P = .12). In the latter cohort (2018–2021), the open approach was no longer superior regarding LTPFS (P = .125). No differences between the three cohorts were found regarding OS (P = .088), length of hospital stay (open approach, P = .065; percutaneous approach, P = .054), and rate and severity of complications (P = .404). The rate and severity of complications favored the percutaneous approach in all three cohorts (P = .002). Conclusion: Over the last 10 years efficacy of percutaneous ablations has improved remarkably for the treatment of CRLM. Oncological outcomes seem to have reached results following open ablation. Given its minimal invasive character and shorter length of hospital stay, whenever feasible, percutaneous procedures may be favored over an open approach.Keywords
This publication has 57 references indexed in Scilit:
- CT-guided Radiofrequency Ablation as a Salvage Treatment of Colorectal Cancer Hepatic Metastases Developing after HepatectomyJournal of Vascular and Interventional Radiology, 2011
- An overview of evidence-based management of hepatocellular carcinoma: A meta-analysisJournal of Cancer Research and Therapeutics, 2011
- Quality Improvement Guidelines for Radiofrequency Ablation of Liver TumoursCardioVascular and Interventional Radiology, 2009
- A Randomized Phase II/III Trial Comparing Hepatectomy Followed by mFOLFOX6 with Hepatectomy Alone as Treatment for Liver Metastasis from Colorectal Cancer: Japan Clinical Oncology Group Study JCOG0603Japanese Journal of Clinical Oncology, 2009
- R1 Resection by Necessity for Colorectal Liver MetastasesAnnals of Surgery, 2008
- The Impact of Margins on Outcome After Hepatic Resection for Colorectal MetastasisAnnals of Surgery, 2007
- Local Recurrences After Intraoperative Radiofrequency Ablation of Liver Metastases: A Comparative Study with Anatomic and Wedge ResectionsAnnals of Surgical Oncology, 2004
- Percutaneous radiofrequency ablation of liver metastases in potential candidates for resectionCancer, 2003
- Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomyBritish Journal of Surgery, 2002
- Ultrasound-guided interventional procedures of the liver during laparoscopySurgical Endoscopy, 2001